無端肽膠原蛋白市場規模、佔有率和成長分析:按原料、純化形式、應用、最終用戶和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2091157

無端肽膠原蛋白市場規模、佔有率和成長分析:按原料、純化形式、應用、最終用戶和地區分類-2026-2033年產業預測

Atelocollagen Market Size, Share, and Growth Analysis, By Source Origin, By Refinement Form, By Application Area, By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球去端肽膠原蛋白市值為 106.7 億美元,預計到 2025 年將成長至 114.1 億美元,到 2033 年將成長至 195 億美元,在預測期(2026-2033 年)內複合年成長率為 6.93%。

全球去端肽膠原蛋白市場以酵素解膠原膠原蛋白供應商為特徵,這些膠原蛋白廣泛應用於醫療、化妝品和膳食補充劑領域。其重要性在於能夠增強細胞黏附並降低過敏反應,這推動了其在皮膚填充劑、創傷治療敷料和膳食補充劑領域的廣泛應用。蛋白水解技術的進步已使去端肽膠原蛋白從一種小眾生物聚合物發展成為一個蓬勃發展的領域。作為安全生物材料獲得監管部門批准,顯著降低了市場准入門檻,促進了臨床應用,從而推動了市場成長。近期技術創新進一步降低了生產成本,並拓展了分銷管道,尤其是在價格敏感型市場。此外,人工智慧在化妝品領域的個人化應用,能夠根據個人需求客製化產品,從而提高消費者參與度,並推動這項快速發展市場的需求成長。

全球去端肽膠原蛋白市場的成長要素

全球去端肽膠原蛋白市場主要受消費者對抗老化療法需求成長的驅動。這源自於消費者越來越傾向選擇能夠提升肌膚水潤度和緊緻度的微創療法。這一趨勢促使生產商拓展產品線,提供多種外用和注射劑型,從而推動了整體市場擴張。去端肽膠原蛋白在改善真皮基質健康方面的公認功效增強了消費者的信心,促進了重複購買和口碑,進而推動了市場進一步成長。此外,這種充滿活力的市場環境也鼓勵了許多新品牌進入美容產業,瞄準特定的市場區隔。

全球去端肽膠原蛋白市場的限制因素

全球去端肽膠原蛋白市場受到提取和純化製程相關高昂生產成本的顯著限制。這些方法不僅複雜,而且需要大量資源、專用設備和嚴格的品管措施,導致單位成本增加。這種經濟負擔可能會降低去端肽膠原蛋白相對於其他生物材料的價格競爭力,使生產商面臨價格壓力。因此,這可能會阻礙注重預算的消費者接受該產品。由此,市場滲透受到阻礙,消費者越來越傾向於尋找具有類似功能優勢的低成本替代品。此外,這種經濟障礙限制了旨在提高產品效率的研發投入,從而抑制了整體市場活力。

全球去端肽膠原蛋白市場趨勢

全球去端肽膠原蛋白市場正經歷著向個人化護膚解決方案的顯著轉變,這主要得益於消費者對客製化美容護理日益成長的需求。製造商們積極響應這一趨勢,將去端肽膠原蛋白融入可客製化的護膚產品中,並利用先進的肽譜分析技術來解決諸如彈性喪失和色素沉著等特定的肌膚問題。這一趨勢不僅支撐了產品的高價位,增強了品牌忠誠度,也促進了透過精品零售商和直銷管道擴大分銷。因此,去端肽膠原蛋白正成為個人化化妝品發展歷程中的關鍵成分,滿足全球市場消費者不斷變化的需求。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球去端肽膠原蛋白市場規模:依原料來源分類

  • 牛源性去端肽膠原蛋白
  • 豬源性去端肽膠原蛋白
  • 海洋來源的去端肽膠原蛋白
  • 其他

全球去端肽膠原蛋白市場規模:以純化形式分類

  • 溶液配方
  • 凍乾粉劑
  • 凝膠型支架配方

全球去端肽膠原蛋白市場規模:按應用領域分類

  • 醫學組織工程與再生醫學
    • 皮膚填充劑和整形手術
    • 創傷護理敷料、止血劑
    • 骨移植替代材料(整形外科)
  • 化妝品和個人護理配方
  • 學術生物製品和調查篩檢

全球去端肽膠原蛋白市場規模:依最終用戶分類

  • 製藥和生物技術公司
  • 醫療設備製造商
  • 研究機構和研究機構

全球去端肽膠原蛋白市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Koken Co
  • Shiseido Company
  • Meiji Holdings
  • Nippon Meat Packers
  • Yamashiroya
  • FUJIFILM Holdings
  • Nitta Gelatin
  • Gelita AG
  • Rousselot
  • Weishardt Group
  • Tessure
  • Collagen Matrix
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Integra LifeSciences
  • Smith & Nephew
  • B. Braun SE
  • Johnson & Johnson
  • Medtronic
  • Baxter International

結論與建議

簡介目錄
Product Code: SQMIG35J2556

Global Atelocollagen Market size was valued at USD 10.67 Billion in 2024 and is poised to grow from USD 11.41 Billion in 2025 to USD 19.5 Billion by 2033, growing at a CAGR of 6.93% during the forecast period (2026-2033).

The global atelocollagen market is characterized by suppliers of enzymatically cleaved collagen utilized across medical, cosmetic, and nutraceutical sectors. Its importance lies in its capacity to enhance cellular adhesion while reducing allergic reactions, fueling its popularity in dermal fillers, wound-healing dressings, and dietary supplements. Technological advancements in proteolytic processing have transformed atelocollagen from a niche biopolymer into a thriving sector. Regulatory recognition as a safe biomaterial has significantly contributed to market growth, as it diminishes entry barriers and fosters clinical adoption. Recent innovations further lower production costs and expand distribution channels, particularly in regions with price-sensitive markets. Additionally, AI-driven personalization in the cosmetics arena tailors product offerings to individual needs, enhancing consumer engagement and driving demand in this rapidly evolving market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atelocollagen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atelocollagen Market Segments Analysis

Global atelocollagen market is segmented by source origin, refinement form, application area, end-user and region. Based on source origin, the market is segmented into Bovine Derived Atelocollagen, Porcine Derived Atelocollagen, Marine Derived Atelocollagen and Others. Based on refinement form, the market is segmented into Solution Formulations, Powdered Lyophilized Formulations and Gel Scaffold Formulations. Based on application area, the market is segmented into Medical Tissue Engineering Regenerative Medicine, Cosmetics Personal Care Formulations and Academic Biologics Research Screenings. Based on end-user, the market is segmented into Pharmaceutical Biotechnology Companies, Medical Device Manufacturers and Research Institutions Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Atelocollagen Market

The global market for atelocollagen is significantly driven by the growing consumer demand for anti-aging treatments, as individuals increasingly favor minimally invasive options that enhance skin hydration and firmness. This trend prompts manufacturers to diversify their product range, offering various topical and injectable formulations, which contributes to overall market expansion. The recognized advantages of atelocollagen in improving the integrity of the dermal matrix instill confidence among consumers, fostering repeat purchases and encouraging recommendations, thereby promoting further growth. Moreover, this dynamic landscape invites new brands to enter the market, aiming to target specific niches within the beauty sector.

Restraints in the Global Atelocollagen Market

The Global Atelocollagen market faces significant growth constraints due to high production costs associated with its extraction and purification processes. These methods are not only complex but also require considerable resources, specialized equipment, and rigorous quality control measures, which contribute to increased unit costs. This financial burden can diminish the price competitiveness of atelocollagen compared to alternative biomaterials, leading manufacturers to confront pricing pressures that may deter adoption among budget-conscious consumers. As a result, broader market penetration is hindered, prompting customers to explore lower-cost substitutes that offer similar functional benefits. Additionally, this economic barrier limits investment in research and development aimed at enhancing product efficiency, stifling overall market dynamism.

Market Trends of the Global Atelocollagen Market

The Global Atelocollagen market is experiencing a significant shift towards personalized skincare solutions driven by increasing consumer demand for tailored beauty regimens. Manufacturers are responding by integrating atelocollagen into customizable skincare products, utilizing advanced peptide profiling to address specific skin concerns like elasticity loss and hyperpigmentation. This trend not only justifies premium pricing and fosters brand loyalty but also enhances distribution through boutique retailers and direct-to-consumer channels. As a result, atelocollagen is emerging as a key ingredient in the evolution of individualized cosmetic offerings, aligning with the dynamic and evolving expectations of consumers across global markets.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Atelocollagen Market Size by Source Origin & CAGR (2026-2033)

  • Market Overview
  • Bovine Derived Atelocollagen
  • Porcine Derived Atelocollagen
  • Marine Derived Atelocollagen
  • Others

Global Atelocollagen Market Size by Refinement Form & CAGR (2026-2033)

  • Market Overview
  • Solution Formulations
  • Powdered Lyophilized Formulations
  • Gel Scaffold Formulations

Global Atelocollagen Market Size by Application Area & CAGR (2026-2033)

  • Market Overview
  • Medical Tissue Engineering Regenerative Medicine
    • Dermal Fillers Plastic Surgery
    • Wound Care Dressings Hemostats
    • Bone Graft Substitutes Orthopedics
  • Cosmetics Personal Care Formulations
  • Academic Biologics Research Screenings

Global Atelocollagen Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical Biotechnology Companies
  • Medical Device Manufacturers
  • Research Institutions Laboratories

Global Atelocollagen Market Size & CAGR (2026-2033)

  • North America (Source Origin, Refinement Form, Application Area, End-User)
    • US
    • Canada
  • Europe (Source Origin, Refinement Form, Application Area, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Source Origin, Refinement Form, Application Area, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Source Origin, Refinement Form, Application Area, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Source Origin, Refinement Form, Application Area, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Koken Co
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shiseido Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meiji Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nippon Meat Packers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yamashiroya
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nitta Gelatin
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gelita AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rousselot
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Weishardt Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tessure
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Collagen Matrix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations